Sherpa Capital logo

Sherpa Capital

Crunchbase
Pitchbook
Crunchbase

Deals on record

1

Common Fundraising Type

Series B

AusperBio logo
AusperBio

Biotechnology

AusperBio is a biotechnology company developing targeted oligonucleotide therapies for chronic hepatitis B and other chronic diseases.

Series B
$73M
12/26/2024
Article